Im Cannabis Corp Stock Today

IMCC Stock  USD 2.07  0.02  0.98%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Very High

 
High
 
Low
Im Cannabis is trading at 2.07 as of the 1st of March 2025, a 0.98% increase since the beginning of the trading day. The stock's open price was 2.05. Im Cannabis has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 12th of March 2023 and ending today, the 1st of March 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
20th of May 2020
Category
Healthcare
Classification
Health Care
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. The company serves medical patients and adult-use recreational consumers. IM Cannabis is traded on NASDAQ Exchange in the United States. The company has 3.09 M outstanding shares of which 6.46 K shares are currently shorted by private and institutional investors with about 0.44 trading days to cover. More on Im Cannabis Corp

Moving against IMCC Stock

  0.43OPT OptheaPairCorr
  0.42PFE Pfizer IncPairCorr
  0.39LTRN Lantern PharmaPairCorr
  0.35FENC Fennec PharmaceuticalsPairCorr
  0.32PHGE Biomx IncPairCorr
  0.31GANX Gain TherapeuticsPairCorr

IMCC Stock Highlights

ESG Sustainability
Environmental
Governance
Social
Executive ChairmanMSc MBA
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover1.091.15
Notably Down
Slightly volatile
Gross Profit Margin0.220.23
Sufficiently Down
Slightly volatile
Total Current Liabilities39.6 M37.7 M
Sufficiently Up
Slightly volatile
Total Assets58.9 M56.1 M
Sufficiently Up
Slightly volatile
Total Current Assets29.3 M27.9 M
Sufficiently Up
Slightly volatile
Debt Levels
Im Cannabis can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Im Cannabis' financial leverage. It provides some insight into what part of Im Cannabis' total assets is financed by creditors.
Liquidity
Im Cannabis Corp currently holds 13.78 M in liabilities with Debt to Equity (D/E) ratio of 0.2, which may suggest the company is not taking enough advantage from borrowing. Im Cannabis Corp has a current ratio of 1.16, suggesting that it may not be capable to disburse its financial obligations when due. Note, when we think about Im Cannabis' use of debt, we should always consider it together with its cash and equity.

Change In Cash

(543,780)
Im Cannabis Corp (IMCC) is traded on NASDAQ Exchange in USA. It is located in Kibbutz Glil Yam, Tel Aviv, Israel, 4690500 and employs 95 people. Im Cannabis is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.45 M. Im Cannabis Corp conducts business under Biotechnology sector and is part of Health Care industry. The entity has 3.09 M outstanding shares of which 6.46 K shares are currently shorted by private and institutional investors with about 0.44 trading days to cover. Im Cannabis Corp currently holds about 5.86 M in cash with (8.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Check Im Cannabis Probability Of Bankruptcy
Ownership Allocation
Im Cannabis shows considerable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.
Check IMCC Ownership Details

IMCC Stock Institutional Holders

InstituionRecorded OnShares
Renaissance Technologies Corp2024-09-30
0.0
Morgan Stanley - Brokerage Accounts2024-09-30
0.0
Advisorshares Investments, Llc2024-12-31
104.1 K
Citadel Advisors Llc2024-09-30
14 K
Bank Of Montreal2024-12-31
12.6 K
Bmo Capital Markets Corp.2024-12-31
12.6 K
Federation Des Caisses Desjardins Du Quebec2024-09-30
1.9 K
Royal Bank Of Canada2024-12-31
290
Bryn Mawr Trust Company2024-12-31
9.0
Sbi Securities Co Ltd2024-12-31
8.0
Td Waterhouse Canada Inc2024-09-30
3.0
View Im Cannabis Diagnostics

Im Cannabis Historical Income Statement

At present, Im Cannabis' Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 58.9 M, whereas Operating Income is projected to grow to (10.9 M). View More Fundamentals

IMCC Stock Against Markets

Im Cannabis Corporate Management

When determining whether Im Cannabis Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Im Cannabis' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Im Cannabis Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Im Cannabis Corp Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Im Cannabis Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Im Cannabis. If investors know IMCC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Im Cannabis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.03)
Revenue Per Share
23.021
Quarterly Revenue Growth
0.122
Return On Assets
(0.15)
Return On Equity
(1.17)
The market value of Im Cannabis Corp is measured differently than its book value, which is the value of IMCC that is recorded on the company's balance sheet. Investors also form their own opinion of Im Cannabis' value that differs from its market value or its book value, called intrinsic value, which is Im Cannabis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Im Cannabis' market value can be influenced by many factors that don't directly affect Im Cannabis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Im Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Im Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Im Cannabis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.